Neurology company Zynerba raises $32.5 million follow-on

Neurology company Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE) raised $32.5 million on July 20 in a follow-on of 4.1 million shares at $8. Cantor Fitzgerald underwrote the offering. The price is a 23% ...